Kitron: Completed share buyback in connection with remuneration to the board members

Udgivet den 13-05-2024  |  kl. 15:36  |  

2024-05-13) Kitron ASA has completed share buyback in connection with remuneration to the board members.

Reference is made to the stock exchange release by Kitron ASA (Kitron or the Company) published on 13. May 2024 regarding initiation of a share buyback program.

The Company has completed its share buyback program. Norne Securities AS has been engaged to carry out the buybacks on behalf of the Company pursuant to the EU Market Abuse Regulation article 5.

The Company has acquired a total of 27,275 own shares at an volume-weighted average price per share of NOK 30.48240. A report of all the transactions relating to the buy-back program, both in detailed and aggregated form, is attached.

The shares acquired are used as part of the remuneration to the board members of the Company for the period from and including May 2024, and to and including April 2025, as resolved by the annual general meeting on 25 April 2024.

After the buyback by the Company, the shares were acquired by the Company's board members as follows:

* Tuomo Lähdesmäki (chairperson) acquired 8,529 shares
* Maalfrid Brath (board member) acquired 2,706 shares
* Michael Lundgaard Thomsen (board member) acquired 4,330 shares
* Petra Grandinson (board member) acquired 4,330 shares
* Gyrid Skalleberg Ingerø (board member) acquired 2,706 shares
* Jarle Larsen (board member) acquired 1,558 shares
* Tone Aas (board member) acquired 1,558 shares
* Henriette Stene (board member) acquired 1,558 shares.

Primary insider notifications pursuant to the market abuse regulation article 19 are attached.

After the buyback and acquisitions by the board members, Kitron does not own any shares in the Company.

For further information, please contact:
Cathrin Nylander, CFO, tel.: +47 900 43 284
E-mail: investorrelations@kitron.com

Kitron is a leading Scandinavian electronics manufacturing services company for the Connectivity, Electrification, Industry, Medical devices and Defence/Aerospace sectors. The group is located in Norway, Sweden, Denmark,Lithuania, Germany, Poland, the Czech Republic, India, Malaysia, China and the
United States. Kitron has about 2 800 employees, and revenues were EUR 775 million in 2023.

www.kitron.com (http://www.kitron.com)

This information is made public by the Company pursuant to the EU market abuse regulation article 5, as supplemented by Commission Delegated Regulation (EU) 2016/1052, and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. Oslo Børs (https://www.euronext.com/nb/markets/oslo)

 

Attachments

KIT Report on repurchase transaction and detailed information 2024 KIT PDMR notifications 2024

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

10:14 Vestas og fransk NKT-konkurrent sænket til "underperform" af finansgigant efter Trump-sejr
09:53 Torm er presset af lavere olietransport ud af Mellemøsten - topchef tror på genopretning
09:39 DFDS-topchef: Finansiel præstation i Ekol-handel blandt årsagerne til aflyst køb
09:25 Aktier/åbning: Lidt højere marked med flotte plusser til GN, Novonesis og Genmab
09:14 Novonesis overrasker med oppræcisering i stærkt tredje kvartal
09:08 Ambus kursmål skåret til 130 kr. efter regnskab hos Redburn
09:06 Obligationer/åbning: Stort set uændret rente på dag med rentemøder
09:02 DFDS' Torben Carlsen ser først økonomisk afmatning i Europa vende i 2025
08:58 Torm fortsætter vækst og betaler udbytte - men lavere fragtpriser giver nedjustering
08:45 Vestas får sænket anbefaling af Bank of America efter Trump-sejr og regnskab
08:31 GN-topchef: Vi når formentlig ikke vending til positivt marked i Enterprise i år
08:31 Aktier/tendens: Ny stime af regnskaber - opjustering fra Novonesis, Genmab, men GN sænker
08:23 Gubra vender driftsindtjeningen til plus i tredje kvartal drevet af fedme
07:49 DFDS' fragtmængder og passagerantal hjulpet af rutetilgang
07:45 Korr: Obligationer/tendens: Udsigt til uændret åbning på dag med rentemøder
07:37 Genmabs lukning i USA indikerer positiv åbning
07:35 Zealand Pharma OVERBLIK Q3: Opmuntrende pipeline overskygger underskud
07:27 Obligationer/tendens: Udsigt til uændret åbning på dag med rentemøder
07:07 Genmabs kursmål sættes ned af amerikanske TD Cowen efter regnskab
07:05 Ørsteds kursmål sænkes hos HSBC efter regnskab og Trump-sejr